← Leaderboards
Bruce L Geller
Siga Technologies, Inc.
$1,138,090
Attributed
$2,024,142
Total exposure
3
Grants
0
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $474.8K · FY2014–18$500K$375K$250K$125K$0
'14
'15
'16
'17
'18
Funding mix
By agency
NIH$2,024,142 · 3
By mechanism
R33$1,357,072 · 1
R21$415,032 · 1
R41$252,038 · 1
Top collaborators
- David Elihu Greenberg5 shared
Others in their field
Top investigators on “Databases”
- David Heimbrook · Leidos Biomedical Research, Inc.$455,970,032
- Margaret Juliana McElrath · Fred Hutchinson Cancer Center$335,843,535
- David R. Weir · University Of Michigan At Ann Arbor$325,731,040
- James Dennis Neaton · Northwestern University$268,647,311
- George R Seage · Abt Associates, Inc.$256,840,535
- Richard K. Wilson · Washington University$204,375,149
Research focus
DatabasesAcinetobacterAcinetobacter BaumanniiConserved SequenceAnimalsAmericasAmpicillinAntibioticsCommunicable DiseasesAntisense TechnologyBacteremiaBacteriaAnti-Bacterial AgentsBacterial GenesBacterial ResistanceAntibiotic ResistanceBactericideBaseAntimicrobialAnimal ModelBurkholderia Cepacia ComplexCell PhysiologyClinical ResearchDesign
Grant awards (6)
Circumventing Antibiotic Resistance with Novel Gene-Silencing Therapeutics$438,783
R33 · FY2018 · AI
Circumventing Antibiotic Resistance with Novel Gene-Silencing Therapeutics$443,512
R33 · FY2017 · AI
Circumventing Antibiotic Resistance with Novel Gene-Silencing Therapeutics$474,777
R33 · FY2016 · AI
Circumventing Antibiotic Resistance with Novel Gene-Silencing Therapeutics$199,973
R21 · FY2015 · AI
Circumventing Antibiotic Resistance with Novel Gene-Silencing Therapeutics$215,059
R21 · FY2014 · AI
Lactococcal vaccine for strep throat$252,038
R41 · FY2004 · AI